Complement activation in human prion disease

The central event in the neuropathological process of prion diseases (PrD) is the accumulation of abnormal prion protein accompanied by severe neuronal loss. Despite the infectious nature of these diseases, no prominent immune response has been detected yet. However, recent studies have shown that c...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of disease Vol. 15; no. 1; pp. 21 - 28
Main Authors Kovacs, Gabor G, Gasque, Philippe, Ströbel, Thomas, Lindeck-Pozza, Elisabeth, Strohschneider, Michaela, Ironside, James W, Budka, Herbert, Guentchev, Marin
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2004
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The central event in the neuropathological process of prion diseases (PrD) is the accumulation of abnormal prion protein accompanied by severe neuronal loss. Despite the infectious nature of these diseases, no prominent immune response has been detected yet. However, recent studies have shown that complement, a component of the innate immune system, is involved in the early pathogenesis of experimental prion infection. Here we demonstrate, in the diseased human brains, the presence of active compounds of the complement system, like C1q and C3b, in extracellular disease-associated prion protein deposits and the membrane attack complex in neurons. The neuronal localization of the membrane attack complex correlates well with the severity of disease-specific pathology and TUNEL labeling of neurons, irrespective of genotype or molecular phenotype of human prion diseases.
AbstractList The central event in the neuropathological process of prion diseases (PrD) is the accumulation of abnormal prion protein accompanied by severe neuronal loss. Despite the infectious nature of these diseases, no prominent immune response has been detected yet. However, recent studies have shown that complement, a component of the innate immune system, is involved in the early pathogenesis of experimental prion infection. Here we demonstrate, in the diseased human brains, the presence of active compounds of the complement system, like C1q and C3b, in extracellular disease-associated prion protein deposits and the membrane attack complex in neurons. The neuronal localization of the membrane attack complex correlates well with the severity of disease-specific pathology and TUNEL labeling of neurons, irrespective of genotype or molecular phenotype of human prion diseases.
The central event in the neuropathological process of prion diseases (PrD) is the accumulation of abnormal prion protein accompanied by severe neuronal loss. Despite the infectious nature of these diseases, no prominent immune response has been detected yet. However, recent studies have shown that complement, a component of the innate immune system, is involved in the early pathogenesis of experimental prion infection. Here we demonstrate, in the diseased human brains, the presence of active compounds of the complement system, like C1q and C3b, in extracellular disease-associated prion protein deposits and the membrane attack complex in neurons. The neuronal localization of the membrane attack complex correlates well with the severity of disease-specific pathology and TUNEL labeling of neurons, irrespective of genotype or molecular phenotype of human prion diseases.The central event in the neuropathological process of prion diseases (PrD) is the accumulation of abnormal prion protein accompanied by severe neuronal loss. Despite the infectious nature of these diseases, no prominent immune response has been detected yet. However, recent studies have shown that complement, a component of the innate immune system, is involved in the early pathogenesis of experimental prion infection. Here we demonstrate, in the diseased human brains, the presence of active compounds of the complement system, like C1q and C3b, in extracellular disease-associated prion protein deposits and the membrane attack complex in neurons. The neuronal localization of the membrane attack complex correlates well with the severity of disease-specific pathology and TUNEL labeling of neurons, irrespective of genotype or molecular phenotype of human prion diseases.
Author Ironside, James W
Lindeck-Pozza, Elisabeth
Strohschneider, Michaela
Kovacs, Gabor G
Ströbel, Thomas
Budka, Herbert
Gasque, Philippe
Guentchev, Marin
Author_xml – sequence: 1
  givenname: Gabor G
  surname: Kovacs
  fullname: Kovacs, Gabor G
  organization: Institute of Neurology, University of Vienna, Vienna, Austria
– sequence: 2
  givenname: Philippe
  surname: Gasque
  fullname: Gasque, Philippe
  organization: Medical Biochemistry Department, College of Medicine, University of Wales, Cardiff, UK
– sequence: 3
  givenname: Thomas
  surname: Ströbel
  fullname: Ströbel, Thomas
  organization: Institute of Neurology, University of Vienna, Vienna, Austria
– sequence: 4
  givenname: Elisabeth
  surname: Lindeck-Pozza
  fullname: Lindeck-Pozza, Elisabeth
  organization: Institute of Neurology, University of Vienna, Vienna, Austria
– sequence: 5
  givenname: Michaela
  surname: Strohschneider
  fullname: Strohschneider, Michaela
  organization: Institute of Neurology, University of Vienna, Vienna, Austria
– sequence: 6
  givenname: James W
  surname: Ironside
  fullname: Ironside, James W
  organization: National CJD Surveillance Unit, University of Edinburgh, Western General Hospital, EH4 2XU Edinburgh, Scotland, UK
– sequence: 7
  givenname: Herbert
  surname: Budka
  fullname: Budka, Herbert
  email: H.Budka@akh-wien.ac.at
  organization: Institute of Neurology, University of Vienna, Vienna, Austria
– sequence: 8
  givenname: Marin
  surname: Guentchev
  fullname: Guentchev, Marin
  organization: Institute of Neurology, University of Vienna, Vienna, Austria
BackLink https://www.ncbi.nlm.nih.gov/pubmed/14751767$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtvFDEQhC0URDaBH8AF7YkTM7Rn_BiLE1pBiBSJC0jcLD_a4GXGs9izkfLv8WaTHHJITu226iu1qs7ISZoTEvKWQkuBio_bNlnfdgB9C6oFCi_IioLijeL9rxOyAiVUo5Sgp-SslC0ApVzJV-SUMsmpFHJFPmzmaTfihGlZG7fEa7PEOa1jWv_ZTyatd_mw-ljQFHxNXgYzFnxzN8_Jz69ffmy-NVffLy43n68ax5RYGmOdtYOEDgfD-iA4Auf1JTrshqGHIFRQXrKBeWG5tcFBx1DwwDwPGFx_Ti6Pvn42W11PmEy-0bOJ-vZjzr-1yUt0I-oeUBhLFePgGVI-GOgllTx4FBB6Vr3eH712ef63x7LoKRaH42gSzvuiB6CdUkw8K-yA90IxWYXv7oR7O6F_uO8-1CqQR4HLcykZg3Zxuc11ySaOmoI-1Ke3utanD_VpULrWV0n6iHwwf4L5dGSwNnIdMeviIiaHPmZ0S40sPkmrR7QbY4rOjH_x5hn2PzIew14
CitedBy_id crossref_primary_10_1016_j_mehy_2006_06_017
crossref_primary_10_1016_j_coi_2004_07_002
crossref_primary_10_1007_s12031_012_9854_x
crossref_primary_10_2353_ajpath_2008_070442
crossref_primary_10_1038_nrmicro1492
crossref_primary_10_1172_JCI90605
crossref_primary_10_1007_s00702_017_1792_x
crossref_primary_10_1097_NEN_0b013e31820805b9
crossref_primary_10_1007_s12035_014_8915_2
crossref_primary_10_1186_s40249_016_0128_7
crossref_primary_10_1016_j_amc_2007_10_062
crossref_primary_10_1371_journal_pone_0239537
crossref_primary_10_1007_s00430_019_00641_6
crossref_primary_10_3390_ijms10030976
crossref_primary_10_1016_j_imlet_2006_03_001
crossref_primary_10_1007_s00018_016_2418_4
crossref_primary_10_3390_ijms22042196
crossref_primary_10_1016_j_ajpath_2018_11_009
crossref_primary_10_1016_j_virol_2011_11_017
crossref_primary_10_1016_j_mehy_2004_07_024
crossref_primary_10_1074_jbc_M506579200
crossref_primary_10_1016_j_imbio_2004_06_003
crossref_primary_10_1371_journal_pone_0149792
crossref_primary_10_1155_2013_342931
crossref_primary_10_1007_s12035_018_1421_1
crossref_primary_10_1007_s00401_004_0953_9
crossref_primary_10_3390_biom10060908
crossref_primary_10_1016_j_brainresrev_2005_12_002
crossref_primary_10_1021_bi047370a
crossref_primary_10_1021_sb400168u
crossref_primary_10_1007_s10875_012_9767_z
crossref_primary_10_1016_j_nbd_2005_01_005
crossref_primary_10_1007_s12035_022_02817_3
crossref_primary_10_1016_j_imlet_2010_03_012
crossref_primary_10_1016_j_ddmec_2004_11_001
crossref_primary_10_1146_annurev_pathmechdis_3_121806_154326
crossref_primary_10_1016_j_yexmp_2005_12_007
crossref_primary_10_1097_01_jnen_0000218445_30535_6f
crossref_primary_10_1016_j_virol_2016_05_014
crossref_primary_10_1016_j_imbio_2007_04_001
crossref_primary_10_1016_j_molimm_2008_02_023
crossref_primary_10_1007_s12026_011_8239_5
crossref_primary_10_1111_j_1460_9568_2006_04801_x
crossref_primary_10_1186_s12864_022_08306_0
crossref_primary_10_1196_annals_1332_010
crossref_primary_10_1016_j_jneuroim_2011_05_006
crossref_primary_10_1016_j_it_2008_11_003
crossref_primary_10_3389_fncel_2021_710390
Cites_doi 10.1097/00005072-199904000-00002
10.1038/86567
10.1172/JCI112372
10.1006/exnr.1999.7170
10.1111/j.1750-3639.2002.tb00417.x
10.1212/WNL.53.4.699
10.1006/nbdi.2002.0477
10.1097/00005072-199805000-00009
10.1074/jbc.273.13.7691
10.1016/S0002-9440(10)64753-0
10.1073/pnas.95.23.13363
10.1161/hq0701.092160
10.1074/jbc.M206448200
10.1002/ana.410430409
10.1002/glia.10146
10.1016/S0161-5890(99)00116-9
10.1016/S0002-9440(10)64604-4
10.1097/00005072-199710000-00005
10.1615/CritRevImmunol.v19.i3.10
10.1523/JNEUROSCI.20-20-07505.2000
10.1016/S0006-8993(99)01514-0
10.1038/86562
10.1016/S0162-3109(97)00059-3
10.1016/S0162-3109(00)80302-1
10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W
ContentType Journal Article
Copyright 2003 Elsevier Inc.
Copyright_xml – notice: 2003 Elsevier Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
DOA
DOI 10.1016/j.nbd.2003.09.010
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Neurosciences Abstracts

MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1095-953X
EndPage 28
ExternalDocumentID oai_doaj_org_article_30e6ab19450d4e158a037175fde60f34
14751767
10_1016_j_nbd_2003_09_010
S0969996103001748
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1~.
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABTEW
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
ADVLN
ADXHL
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AIEXJ
AIGII
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
G-Q
GBLVA
GROUPED_DOAJ
HVGLF
HZ~
IHE
J1W
K-O
KOM
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OK1
OP~
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SSH
SSN
SSZ
T5K
X7M
XPP
Z5R
ZGI
ZMT
ZU3
~G-
0SF
6I.
AACTN
AADPK
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AHPSJ
AJBFU
AJOXV
AMFUW
EFLBG
LCYCR
NCXOZ
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7TK
7X8
ID FETCH-LOGICAL-c496t-abcbb8702e8a43f65e055a4362e28830f69f9d7484d6b5bbfc024e65f4d5fefc3
IEDL.DBID DOA
ISSN 0969-9961
IngestDate Wed Aug 27 01:33:31 EDT 2025
Fri Jul 11 09:47:59 EDT 2025
Tue Aug 05 10:17:33 EDT 2025
Wed Feb 19 01:44:01 EST 2025
Thu Apr 24 23:44:16 EDT 2025
Tue Jul 01 03:07:08 EDT 2025
Fri Feb 23 02:29:34 EST 2024
Tue Aug 26 17:15:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Membrane attack complex
Prion disease
Complement
Creutzfeldt–Jakob disease
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c496t-abcbb8702e8a43f65e055a4362e28830f69f9d7484d6b5bbfc024e65f4d5fefc3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://doaj.org/article/30e6ab19450d4e158a037175fde60f34
PMID 14751767
PQID 20536947
PQPubID 23462
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_30e6ab19450d4e158a037175fde60f34
proquest_miscellaneous_80129946
proquest_miscellaneous_20536947
pubmed_primary_14751767
crossref_citationtrail_10_1016_j_nbd_2003_09_010
crossref_primary_10_1016_j_nbd_2003_09_010
elsevier_sciencedirect_doi_10_1016_j_nbd_2003_09_010
elsevier_clinicalkey_doi_10_1016_j_nbd_2003_09_010
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-02-01
PublicationDateYYYYMMDD 2004-02-01
PublicationDate_xml – month: 02
  year: 2004
  text: 2004-02-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Neurobiology of disease
PublicationTitleAlternate Neurobiol Dis
PublicationYear 2004
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Prusiner (BIB19) 1998; 95
Yasojima, McGeer, McGeer (BIB29) 1999; 833
Adler, Baker, Johnson, Ochi, Pritzl, Couser (BIB1) 1986; 77
Ironside (BIB10) 2000; 16
Klein, Kaeser, Schwarz, Weyd, Xenarios, Zinkernagel, Carroll, Verbeek, Botto, Walport, Molina, Kalinke, Acha-Orbea, Aguzzi (BIB12) 2001; 7
Stadelmann, Bruck, Bancher, Jellinger, Lassmann (BIB24) 1998; 57
Yang, Li, Meri, Rogers, Shen (BIB28) 2000; 20
Budka (BIB2) 2000; 16
Guentchev, Siedlak, Jarius, Tagliavini, Castellani, Perry, Smith, Budka (BIB9) 2002; 9
Ishii, Haga, Yagishita, Tateishi (BIB11) 1984; 2
Eikelenboom, Bate, Van Gool, Hoozemans, Rozemuller, Veerhuis, Williams (BIB5) 2002; 40
Stoltzner, Grenfell, Mori, Wisniewski, Wisniewski, Selkoe, Lemere (BIB25) 2000; 156
Parchi, Giese, Capellari, Brown, Schulz-Schaeffer, Windl, Zerr, Budka, Kopp, Piccardo, Poser, Rojiani, Streichemberger, Julien, Vital, Ghetti, Gambetti, Kretzschmar (BIB18) 1999; 46
Whitney, Andrews, McNamara (BIB27) 1999; 53
Dandoy-Dron, Guillo, Benboudjema, Deslys, Lasmezas, Dormont, Tovey, Dron (BIB4) 1998; 273
Gasque, Dean, McGreal, VanBeek, Morgan (BIB6) 2000; 49
Morgan, Gasque, Singhrao, Piddlesden (BIB16) 1997; 38
Makrides (BIB15) 1998; 50
Singhrao, Neal, Rushmere, Morgan, Gasque (BIB23) 2000; 157
Kovacs, Head, Hegyi, Bunn, Flicker, Hainfellner, McCardle, Laszlo, Jarius, Ironside, Budka (BIB13) 2002; 12
Morgan (BIB17) 1999; 19
Storch, Piddlesden, Haltia, Iivanainen, Morgan, Lassmann (BIB26) 1998; 43
Yasojima, Schwab, McGeer, McGeer (BIB30) 2001; 21
Guentchev, Hainfellner, Trabattoni, Budka (BIB8) 1997; 56
Collard, Lekowski, Jordan, Agah, Stahl (BIB3) 1999; 36
Rostagno, Revesz, Lashley, Tomidokoro, Magnotti, Braendgaard, Plant, Bojsen-Moller, Holton, Frangione, Ghiso (BIB20) 2002; 277
Gray, Chretien, Adle-Biassette, Dorandeu, Ereau, Delisle, Kopp, Ironside, Vital (BIB7) 1999; 58
Mabbott, Bruce, Botto, Walport, Pepys (BIB14) 2001; 7
Singhrao, Neal, Morgan, Gasque (BIB21) 1999; 159
Singhrao, Neal, Rushmere, Morgan, Gasque (BIB22) 1999; 79
Stadelmann (10.1016/j.nbd.2003.09.010_BIB24) 1998; 57
Klein (10.1016/j.nbd.2003.09.010_BIB12) 2001; 7
Yasojima (10.1016/j.nbd.2003.09.010_BIB30) 2001; 21
Rostagno (10.1016/j.nbd.2003.09.010_BIB20) 2002; 277
Eikelenboom (10.1016/j.nbd.2003.09.010_BIB5) 2002; 40
Guentchev (10.1016/j.nbd.2003.09.010_BIB8) 1997; 56
Budka (10.1016/j.nbd.2003.09.010_BIB2) 2000; 16
Singhrao (10.1016/j.nbd.2003.09.010_BIB21) 1999; 159
Gasque (10.1016/j.nbd.2003.09.010_BIB6) 2000; 49
Ironside (10.1016/j.nbd.2003.09.010_BIB10) 2000; 16
Storch (10.1016/j.nbd.2003.09.010_BIB26) 1998; 43
Singhrao (10.1016/j.nbd.2003.09.010_BIB22) 1999; 79
Yang (10.1016/j.nbd.2003.09.010_BIB28) 2000; 20
Stoltzner (10.1016/j.nbd.2003.09.010_BIB25) 2000; 156
Guentchev (10.1016/j.nbd.2003.09.010_BIB9) 2002; 9
Ishii (10.1016/j.nbd.2003.09.010_BIB11) 1984; 2
Morgan (10.1016/j.nbd.2003.09.010_BIB16) 1997; 38
Makrides (10.1016/j.nbd.2003.09.010_BIB15) 1998; 50
Collard (10.1016/j.nbd.2003.09.010_BIB3) 1999; 36
Dandoy-Dron (10.1016/j.nbd.2003.09.010_BIB4) 1998; 273
Adler (10.1016/j.nbd.2003.09.010_BIB1) 1986; 77
Morgan (10.1016/j.nbd.2003.09.010_BIB17) 1999; 19
Gray (10.1016/j.nbd.2003.09.010_BIB7) 1999; 58
Yasojima (10.1016/j.nbd.2003.09.010_BIB29) 1999; 833
Singhrao (10.1016/j.nbd.2003.09.010_BIB23) 2000; 157
Prusiner (10.1016/j.nbd.2003.09.010_BIB19) 1998; 95
Whitney (10.1016/j.nbd.2003.09.010_BIB27) 1999; 53
Kovacs (10.1016/j.nbd.2003.09.010_BIB13) 2002; 12
Parchi (10.1016/j.nbd.2003.09.010_BIB18) 1999; 46
Mabbott (10.1016/j.nbd.2003.09.010_BIB14) 2001; 7
References_xml – volume: 79
  start-page: 1247
  year: 1999
  end-page: 1259
  ident: BIB22
  article-title: Differential expression of individual complement regulators in the brain and choroid plexus
  publication-title: Lab. Invest.
– volume: 50
  start-page: 59
  year: 1998
  end-page: 87
  ident: BIB15
  article-title: Therapeutic inhibition of the complement system
  publication-title: Pharmacol. Rev.
– volume: 43
  start-page: 465
  year: 1998
  end-page: 471
  ident: BIB26
  article-title: Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination
  publication-title: Ann. Neurol.
– volume: 159
  start-page: 362
  year: 1999
  end-page: 376
  ident: BIB21
  article-title: Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease
  publication-title: Exp. Neurol.
– volume: 46
  start-page: 224
  year: 1999
  end-page: 233
  ident: BIB18
  article-title: Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects
  publication-title: Ann. Neurol.
– volume: 277
  start-page: 49782
  year: 2002
  end-page: 49790
  ident: BIB20
  article-title: Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease
  publication-title: J. Biol. Chem.
– volume: 21
  start-page: 1214
  year: 2001
  end-page: 1219
  ident: BIB30
  article-title: Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques
  publication-title: Arterioscler., Thromb., Vasc. Biol.
– volume: 36
  start-page: 941
  year: 1999
  end-page: 948
  ident: BIB3
  article-title: Complement activation following oxidative stress
  publication-title: Mol. Immunol.
– volume: 95
  start-page: 13363
  year: 1998
  end-page: 13383
  ident: BIB19
  article-title: Prions
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 58
  start-page: 321
  year: 1999
  end-page: 328
  ident: BIB7
  article-title: Neuronal apoptosis in Creutzfeldt–Jakob disease
  publication-title: J. Neuropathol. Exp. Neurol.
– volume: 9
  start-page: 275
  year: 2002
  end-page: 281
  ident: BIB9
  article-title: Oxidative damage to nucleic acids in human prion disease
  publication-title: Neurobiol Dis.
– volume: 273
  start-page: 7691
  year: 1998
  end-page: 7697
  ident: BIB4
  article-title: Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts
  publication-title: J. Biol. Chem.
– volume: 19
  start-page: 173
  year: 1999
  end-page: 198
  ident: BIB17
  article-title: Regulation of the complement membrane attack pathway
  publication-title: Crit. Rev. Immunol.
– volume: 7
  start-page: 485
  year: 2001
  end-page: 487
  ident: BIB14
  article-title: Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie
  publication-title: Nat. Med.
– volume: 12
  start-page: 1
  year: 2002
  end-page: 11
  ident: BIB13
  article-title: Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes
  publication-title: Brain Pathol.
– volume: 157
  start-page: 905
  year: 2000
  end-page: 918
  ident: BIB23
  article-title: Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis
  publication-title: Am. J. Pathol.
– volume: 53
  start-page: 699
  year: 1999
  end-page: 708
  ident: BIB27
  article-title: Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis
  publication-title: Neurology
– volume: 16
  start-page: 135
  year: 2000
  end-page: 142
  ident: BIB2
  article-title: Histopathology and immunohistochemistry of human transmissible spongiform encephalopathies (TSEs)
  publication-title: Arch. Virol., Suppl.
– volume: 49
  start-page: 171
  year: 2000
  end-page: 186
  ident: BIB6
  article-title: Complement components of the innate immune system in health and disease in the CNS
  publication-title: Immunopharmacology
– volume: 156
  start-page: 489
  year: 2000
  end-page: 499
  ident: BIB25
  article-title: Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease
  publication-title: Am. J. Pathol.
– volume: 833
  start-page: 297
  year: 1999
  end-page: 301
  ident: BIB29
  article-title: Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease
  publication-title: Brain Res.
– volume: 77
  start-page: 762
  year: 1986
  end-page: 767
  ident: BIB1
  article-title: Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells
  publication-title: J. Clin. Invest.
– volume: 56
  start-page: 1119
  year: 1997
  end-page: 1124
  ident: BIB8
  article-title: Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt–Jakob disease
  publication-title: J. Neuropathol. Exp. Neurol.
– volume: 16
  start-page: 143
  year: 2000
  end-page: 151
  ident: BIB10
  article-title: Pathology of variant Creutzfeldt–Jakob disease
  publication-title: Arch. Virol., Suppl.
– volume: 2
  start-page: 370
  year: 1984
  end-page: 379
  ident: BIB11
  article-title: The presence of complements in amyloid plaques of Creutzfeldt–Jakob disease and Gerstmann–Straussler–Scheinker disease
  publication-title: Appl. Pathol.
– volume: 20
  start-page: 7505
  year: 2000
  end-page: 7509
  ident: BIB28
  article-title: Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease
  publication-title: J. Neurosci.
– volume: 38
  start-page: 43
  year: 1997
  end-page: 50
  ident: BIB16
  article-title: The role of complement in disorders of the nervous system
  publication-title: Immunopharmacology
– volume: 7
  start-page: 488
  year: 2001
  end-page: 492
  ident: BIB12
  article-title: Complement facilitates early prion pathogenesis
  publication-title: Nat. Med.
– volume: 57
  start-page: 456
  year: 1998
  end-page: 464
  ident: BIB24
  article-title: Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis
  publication-title: J. Neuropathol. Exp. Neurol.
– volume: 40
  start-page: 9
  year: 2002
  end-page: 232
  ident: BIB5
  article-title: Neuroinflammation in Alzheimer's disease and prion disease
  publication-title: Glia
– volume: 16
  start-page: 135
  year: 2000
  ident: 10.1016/j.nbd.2003.09.010_BIB2
  article-title: Histopathology and immunohistochemistry of human transmissible spongiform encephalopathies (TSEs)
  publication-title: Arch. Virol., Suppl.
– volume: 58
  start-page: 321
  year: 1999
  ident: 10.1016/j.nbd.2003.09.010_BIB7
  article-title: Neuronal apoptosis in Creutzfeldt–Jakob disease
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/00005072-199904000-00002
– volume: 7
  start-page: 488
  year: 2001
  ident: 10.1016/j.nbd.2003.09.010_BIB12
  article-title: Complement facilitates early prion pathogenesis
  publication-title: Nat. Med.
  doi: 10.1038/86567
– volume: 77
  start-page: 762
  year: 1986
  ident: 10.1016/j.nbd.2003.09.010_BIB1
  article-title: Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI112372
– volume: 159
  start-page: 362
  year: 1999
  ident: 10.1016/j.nbd.2003.09.010_BIB21
  article-title: Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease
  publication-title: Exp. Neurol.
  doi: 10.1006/exnr.1999.7170
– volume: 12
  start-page: 1
  year: 2002
  ident: 10.1016/j.nbd.2003.09.010_BIB13
  article-title: Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes
  publication-title: Brain Pathol.
  doi: 10.1111/j.1750-3639.2002.tb00417.x
– volume: 53
  start-page: 699
  year: 1999
  ident: 10.1016/j.nbd.2003.09.010_BIB27
  article-title: Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis
  publication-title: Neurology
  doi: 10.1212/WNL.53.4.699
– volume: 16
  start-page: 143
  year: 2000
  ident: 10.1016/j.nbd.2003.09.010_BIB10
  article-title: Pathology of variant Creutzfeldt–Jakob disease
  publication-title: Arch. Virol., Suppl.
– volume: 9
  start-page: 275
  year: 2002
  ident: 10.1016/j.nbd.2003.09.010_BIB9
  article-title: Oxidative damage to nucleic acids in human prion disease
  publication-title: Neurobiol Dis.
  doi: 10.1006/nbdi.2002.0477
– volume: 79
  start-page: 1247
  year: 1999
  ident: 10.1016/j.nbd.2003.09.010_BIB22
  article-title: Differential expression of individual complement regulators in the brain and choroid plexus
  publication-title: Lab. Invest.
– volume: 57
  start-page: 456
  year: 1998
  ident: 10.1016/j.nbd.2003.09.010_BIB24
  article-title: Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/00005072-199805000-00009
– volume: 273
  start-page: 7691
  year: 1998
  ident: 10.1016/j.nbd.2003.09.010_BIB4
  article-title: Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.273.13.7691
– volume: 156
  start-page: 489
  year: 2000
  ident: 10.1016/j.nbd.2003.09.010_BIB25
  article-title: Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)64753-0
– volume: 95
  start-page: 13363
  year: 1998
  ident: 10.1016/j.nbd.2003.09.010_BIB19
  article-title: Prions
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.95.23.13363
– volume: 21
  start-page: 1214
  year: 2001
  ident: 10.1016/j.nbd.2003.09.010_BIB30
  article-title: Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques
  publication-title: Arterioscler., Thromb., Vasc. Biol.
  doi: 10.1161/hq0701.092160
– volume: 277
  start-page: 49782
  year: 2002
  ident: 10.1016/j.nbd.2003.09.010_BIB20
  article-title: Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M206448200
– volume: 43
  start-page: 465
  year: 1998
  ident: 10.1016/j.nbd.2003.09.010_BIB26
  article-title: Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.410430409
– volume: 40
  start-page: 9
  year: 2002
  ident: 10.1016/j.nbd.2003.09.010_BIB5
  article-title: Neuroinflammation in Alzheimer's disease and prion disease
  publication-title: Glia
  doi: 10.1002/glia.10146
– volume: 36
  start-page: 941
  year: 1999
  ident: 10.1016/j.nbd.2003.09.010_BIB3
  article-title: Complement activation following oxidative stress
  publication-title: Mol. Immunol.
  doi: 10.1016/S0161-5890(99)00116-9
– volume: 50
  start-page: 59
  year: 1998
  ident: 10.1016/j.nbd.2003.09.010_BIB15
  article-title: Therapeutic inhibition of the complement system
  publication-title: Pharmacol. Rev.
– volume: 157
  start-page: 905
  year: 2000
  ident: 10.1016/j.nbd.2003.09.010_BIB23
  article-title: Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)64604-4
– volume: 2
  start-page: 370
  year: 1984
  ident: 10.1016/j.nbd.2003.09.010_BIB11
  article-title: The presence of complements in amyloid plaques of Creutzfeldt–Jakob disease and Gerstmann–Straussler–Scheinker disease
  publication-title: Appl. Pathol.
– volume: 56
  start-page: 1119
  year: 1997
  ident: 10.1016/j.nbd.2003.09.010_BIB8
  article-title: Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt–Jakob disease
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/00005072-199710000-00005
– volume: 19
  start-page: 173
  year: 1999
  ident: 10.1016/j.nbd.2003.09.010_BIB17
  article-title: Regulation of the complement membrane attack pathway
  publication-title: Crit. Rev. Immunol.
  doi: 10.1615/CritRevImmunol.v19.i3.10
– volume: 20
  start-page: 7505
  year: 2000
  ident: 10.1016/j.nbd.2003.09.010_BIB28
  article-title: Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.20-20-07505.2000
– volume: 833
  start-page: 297
  year: 1999
  ident: 10.1016/j.nbd.2003.09.010_BIB29
  article-title: Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease
  publication-title: Brain Res.
  doi: 10.1016/S0006-8993(99)01514-0
– volume: 7
  start-page: 485
  year: 2001
  ident: 10.1016/j.nbd.2003.09.010_BIB14
  article-title: Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie
  publication-title: Nat. Med.
  doi: 10.1038/86562
– volume: 38
  start-page: 43
  year: 1997
  ident: 10.1016/j.nbd.2003.09.010_BIB16
  article-title: The role of complement in disorders of the nervous system
  publication-title: Immunopharmacology
  doi: 10.1016/S0162-3109(97)00059-3
– volume: 49
  start-page: 171
  year: 2000
  ident: 10.1016/j.nbd.2003.09.010_BIB6
  article-title: Complement components of the innate immune system in health and disease in the CNS
  publication-title: Immunopharmacology
  doi: 10.1016/S0162-3109(00)80302-1
– volume: 46
  start-page: 224
  year: 1999
  ident: 10.1016/j.nbd.2003.09.010_BIB18
  article-title: Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects
  publication-title: Ann. Neurol.
  doi: 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W
SSID ssj0011597
Score 2.0159254
Snippet The central event in the neuropathological process of prion diseases (PrD) is the accumulation of abnormal prion protein accompanied by severe neuronal loss....
SourceID doaj
proquest
pubmed
crossref
elsevier
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 21
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Antibodies - immunology
Antibody Specificity
Brain - immunology
Brain - physiopathology
Complement
Complement C1q - immunology
Complement C3b - immunology
Complement Membrane Attack Complex - immunology
Complement System Proteins - immunology
Creutzfeldt–Jakob disease
Female
Humans
Immunity, Innate - immunology
Immunohistochemistry
Male
Membrane attack complex
Middle Aged
Neurons - immunology
Prion disease
Prion Diseases - immunology
PrPSc Proteins - immunology
SummonAdditionalLinks – databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  dbid: AIKHN
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED91RUJ7mUbZR2FseZj2MBE1bWwneSwI1IHgZSDxZtnxeeq0pVVXHvjvuXOcMh5g0t4Sx06s8_nunLv7HcBnowzZFaVPEZWlAwqthfW1TzMx9sIIVZaOE5wvLtXsWpzdyJseHHe5MBxWGWV_K9ODtI4to0jN0XI-H30n45utda6TRWwlyhewNcmprQ9b02_ns8uNM4E0dsiapmcpD-icmyHMq7EtXmhAO-U82r_UU0Dxf6SlnrJCgzY6fQ2vohmZTNuZ7kAPmwHsThs6Qv--S74kIbAz_DEfwPZF9J_vwiFv_zZgPOGMhvZ_bDJvklCrL1mu-DY6bd7A9enJ1fEsjfUS0lpUap0aW1tL-2-CpRG5VxIzKelKTZBrCmdeVb5yDB7qlJWW1oQUNCrphZMefZ2_hX6zaPA9JKTDjEGUyIB93jmDNYkCdK6WREDphpB1ZNJ1BBPnmha_dBc19lMTZbnIZa6zShNlh_B1M2TZImk81_mIab_pyCDYoWGx-qEjF2iakDJ2XAmZOYFjWRrGHyykd6gyn4shTLqV012eKUlGetH8uS-LzaBHjPivYZ861tC0QdnrYhpc3P6hTjJXlSie7sFGQlUJNYR3LU890EcUclyoYu__JrUPL9tAI46--QD99eoWD8iGWtuPcY_cA9l-F5U
  priority: 102
  providerName: Elsevier
Title Complement activation in human prion disease
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0969996103001748
https://dx.doi.org/10.1016/j.nbd.2003.09.010
https://www.ncbi.nlm.nih.gov/pubmed/14751767
https://www.proquest.com/docview/20536947
https://www.proquest.com/docview/80129946
https://doaj.org/article/30e6ab19450d4e158a037175fde60f34
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NT90wDLcGkxAXxOf2-HjrYdphWlnfa5K2xwcCPdhAaBoStyhpHIkJCoLHgQt_O3bSPuAAXHbqh5K2cuzaju2fAb4aZciuKH2KqCw5KLQW1tc-zcTACyNUWToucD46VuNTcXgmz561-uKcsAgPHAn3M89QGUuutsycwIEsDYPMFdI7VJnPAxIo6bzOmWrjB6Skiy6GGbK5GhthQQOoKZfLPtNCAaz_hTJ6zdgMSmd_ERZaazEZxa9cgg_YLMPKqCFP-fI--ZaE_M2wMb4Mc0dtmHwFfrCUx7zwhAsX4rZrct4koSVfcn3Dl21sZhVO9_f-7o7Tti1CWotKTVJja2tJzIZYGpF7JTGTks7UELl1cOZV5SvHGKFOWWmJ9KSHUUkvnPTo63wNZpurBj9DQqrKGESJjMvnnTNYk8Sjc7WsyNRxPcg6Mum6xQzn1hUXuksO-6eJstzLMtdZpYmyPfg-nXIdATPeGrzDtJ8OZKzrcIM4QLccoN_jgB4Mu5XTXTkp_QDpQedvvVlMJ7W2RrQh3pv2pWMNTXLIwRXT4NXdLQ2SuapE8foItgWqSqgefIo89UQfUchBoYr1_0GODZiP2UWccrMJs5ObO9wiw2li-zCz_TDow8fR7p_fJ3w8-DU-7gfJeQR6YxfH
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkNpeEI-2LFDIoeqharrZje0kR4pAS8tyKUjcLDseV1uV7Gq7HHrpb2fGcbblAJW4JdE4scbzcjzzDcA7owzFFaVPEZWlDQqthfW1TzMx8MIIVZaOC5zHF2p0Jb5cy-sVOO5qYTitMtr-1qYHax2f9CM3-7PJpP-Ngm-O1rlPFomVKJ_BmiD1Ze389GeZ50ERT-iwwtQpk3dHmyHJq7EtWmjAOuUq2n-cU8Dwv-ejHopBgy863YD1GEQmR-08N2EFmy3YPmpoA33zO3mfhLTO8L98C56P4-n5Nnxk5W_TxROuZ2j_xiaTJgmd-pLZnG_jkc0ruDo9uTwepbFbQlqLSi1SY2trSfuGWBqReyUxk5Ku1BC5o3DmVeUrx9ChTllpaUXIPaOSXjjp0df5a1htpg3uQEIezBhEiQzX550zWJMhQOdqSQyUrgdZxyZdRyhx7mjxU3c5Yz80cZZbXOY6qzRxtgcflkNmLY7GY8SfmfdLQobADg-m8-86yoCmCSljB5WQmRM4kKVh9MFCeocq87nowbBbOd1VmZJdpBdNHvuyWA66J4b_G3bYiYYm9eQzF9Pg9PYXEclcVaJ4mIJDhKoSqgdvWpn6yx9RyEGhit2nTeoQXowux-f6_Ozi6x68bFOOOA9nH1YX81t8S9HUwh4EbbkDsIEZVw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Complement+activation+in+human+prion+disease&rft.jtitle=Neurobiology+of+disease&rft.au=Gabor+G+Kovacs&rft.au=Philippe+Gasque&rft.au=Thomas+Str%C3%B6bel&rft.au=Elisabeth+Lindeck-Pozza&rft.date=2004-02-01&rft.pub=Elsevier&rft.eissn=1095-953X&rft.volume=15&rft.issue=1&rft.spage=21&rft.epage=28&rft_id=info:doi/10.1016%2Fj.nbd.2003.09.010&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_30e6ab19450d4e158a037175fde60f34
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0969-9961&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0969-9961&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0969-9961&client=summon